Humalog Pen Information

KwikPen™ Prefilled with the Humalog Brand of Insulins
separetorPrinter Friendly Version
KwikPen is an easy-to-use, easy-to-inject pen that comes prefilled with Humalog, Humalog Mix75/25, or Humalog Mix50/50.*1 This small, lightweight, portable pen can be used just about anywhere — there is no refrigeration needed after first use so you don't have to worry about being near a fridge. You use one KwikPen at a time and leave unopened KwikPens in the refrigerator.



Easy to use, easy to inject*1
With KwikPen, it's easy to set your dose: simply turn the dose knob in one-unit increments (up to 60 units) to your desired dose. If you dial too much, simply turn the knob back to your correct dose. And KwikPen comes prefilled, so there's no cartridge changing required.



Before use, patients are advised to carefully read the User Manual and Patient Information provided with the Pen.

Original Prefilled Pens Also Available


Humalog, Humalog Mix75/25, and Humalog Mix50/50 are available by prescription only. See Humalog, Humalog Mix75/25, and Humalog Mix50/50 Patient Information for important facts about these products.

* KwikPen Design Validation User Study included adult male and female participants with type 1 and type 2 diabetes. Of the total 150 study participants, 56 were insulin-naive, 42 were currently administering insulin with a vial and syringe, and 52 were experienced insulin pen users.

† Discard 28 days after first use for Humalog KwikPen and 10 days after first use for Humalog Mix75/25 KwikPen and Humalog Mix50/50 KwikPen.

References:
1. Data on file, Eli Lilly and Company (HUM20071024A).


Important Safety Information
Humalog, Humalog Mix75/25, and Humalog Mix50/50 are for use in patients with diabetes to control high blood sugar. Humalog should be used with a longer-acting insulin, except when used in combination with sulfonylureas in patients with type 2 diabetes.

Humalog insulins are contraindicated during episodes of hypoglycemia and in patients sensitive to Humalog or one of its excipients. The safety and effectiveness of Humalog in patients less than 3 years of age have not been established. Safety and effectiveness of Humalog Mix75/25 and Humalog Mix50/50 in patients less than 18 years of age have not been established. There are no clinical studies of the use of Humalog insulins in pregnancy or nursing mothers.

Potential side effects associated with the use of all insulins include low blood sugar, weight gain, low blood potassium, changes in fat tissue at the site of injection, and allergic reactions, both general and local. Humalog Mix75/25 and Humalog Mix50/50 should not be mixed with another insulin. Starting or changing insulin therapy should be done cautiously and only under medical supervision.

Humalog insulins are available by prescription only. See the Humalog, Humalog Mix75/25, and Humalog Mix50/50 Patient Product Information for important facts about these products.

Humalog is a registered trademark of Eli Lilly and Company. Humalog Mix75/25 and Humalog Mix50/50 are trademarks of Eli Lilly and Company.



Humalog Patient Information | Humalog Mix75/25 Patient Information | Humalog Mix50/50 Patient Information | Important Safety Information